Matthew Strobeck Biodesix Inc (BDSX) insider trading activity

Matthew Strobeck is of BIODESIX INC. Currently has a direct ownership of 2.54 Million shares of BDSX, which is worth approximately $3.25 Million. The most recent transaction as insider was on Aug 03, 2023, when has been sold 127,777 shares (Common Stock) at a price of $1.62 per share, resulting in proceeds of $206,998. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.54M

0% 3M change

0% 12M change

Total Value Held $3.25 Million

Matthew Strobeck Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 03 2023	BUY Grant, award, or other acquisition	$206,998 $1.62 p/Share	127,777 Added 4.78%	2,542,928 Common Stock
Nov 21 2022	BUY Open market or private purchase	$999,999 $1.15 p/Share	869,565 Added 26.47%	2,415,151 Common Stock
Apr 07 2022	BUY Open market or private purchase	$1,000,000 $1.79 p/Share	558,659 Added 26.55%	1,545,586 Common Stock
Mar 31 2022	BUY Exercise of conversion of derivative security	-	20,044 Added 1.99%	986,927 Common Stock
Dec 07 2020	BUY Exercise of conversion of derivative security	$400,218 $6.83 p/Share	58,597 Added 5.71%	966,975 Common Stock
Oct 30 2020	BUY Conversion of derivative security	$13,080,643 $14.4 p/Share	908,378 Added 50.0%	908,378 Common Stock

Also insider at

AXDX

Accelerate Diagnostics, Inc Healthcare

Director

QDEL

QuidelOrtho Corp Healthcare